Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
Pansoft
300996
Sublime China Information
301299
CN Stock MarketDetailed Quotes
688238 Obio Technology
- 4.65
- +0.01+0.22%
Market Closed Jan 27 15:00 CST
3.02BMarket Cap-12.24P/E (TTM)
4.75High4.63Low54.00KlotVolume4.65Open4.64Pre Close25.36MTurnover1.16%Turnover RatioLossP/E (Static)649.04MShares7.3852wk High1.61P/B2.17BFloat Cap3.8652wk Low5.57Limit Up466.74MShs Float27.31Historical High3.71Limit Down2.59%Amplitude3.86Historical Low--Dividend TTM4.70Avg Price25.71KlotAsk--Div YieldTTM100Lot Size27.98KlotBid
Obio Technology News
Heyuan Biotech: Opinions of Haitong Securities Co., Ltd. on the resignation of Heyuan Biotech (Shanghai) Co., Ltd. directors, senior management and core technicians and new certification of core technicians
Heyuan Biotech: Constitution of Heyuan Biotechnology (Shanghai) Co., Ltd.
Constitution of Heyuan Biotechnology (Shanghai) Co., Ltd.
Heyuan Biotech Investor Relations Activity Record Form (December 5 and 17, 2024)
Heyuan Biotech Investor Relations Activity Record List (November 13 and 14, 2024)
Heyuan Biotech Investor Relations Activity Record Form (2024 Third Quarter Results Briefing)
Heyuan Biotech Investor Relations Activity Record List (October 24, 2024)
Heyuan Biotech: Announcement on asset impairment preparations for the first three quarters of 2024
Heyuan Biotech: Announcement on holding the results briefing for the third quarter of 2024
Announcement on holding the results briefing for the third quarter of 2024
Heyuan Biotech: Haitong Securities Co., Ltd.\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Haitong Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Heyuan Biotech Investor Relations Activity Record List (August 29, 2024)
Heyuan Biotech Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Announcement on holding the 2024 semi-annual results briefing
Resolutions of the Third Meeting of the Third Special Meeting of Independent Directors of the Board of Directors
Special report on the storage and actual use of funds raised in the 2024 semi-year
Announcement of Resolutions of the 11th Meeting of the Third Board of Supervisors
Verification opinions on the regulatory inquiry letter for the 2023 annual report of Heyuan Biotechnology (Shanghai) Co., Ltd. disclosed by Haitong Securities Co., Ltd.
Heyuan Biotech Investor Relations Activity Record Form (2023 and 2024 First Quarter Results Briefing)
